Image collection for early upper gastrointestinal cancer and precancerous conditions
Official title: Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions
Run by Changhai Hospital · NCT07462247 · Data updated 2026-11-12
This project will collect capsule endoscopy, endoscopy, CT, and biopsy images from adults with early upper gastrointestinal cancer or precancerous conditions to build an image database to support better image-based diagnosis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | March 11, 2026 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT07462247 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) referred for endoscopic submucosal dissection for early upper GI cancer or for EGD biopsy of upper GI precancerous lesions/conditions who can undergo the imaging procedures and provide informed consent are ideal candidates.
✕Probably not a fit
Patients with swallowing difficulties, suspected intestinal stenosis, implanted electromagnetic devices, pregnancy, or those unwilling/unable to undergo the imaging procedures are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational effort will gather magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, CT scans, and corresponding histopathology results from patients undergoing ESD or biopsy for early upper gastrointestinal cancer and precancerous lesions/conditions. Collected images and pathology will be linked and curated to form a standardized database suitable for training and validating image-based deep learning models. Participants must be adults able to consent and tolerate the procedures; standard exclusions apply for capsule retention risk, implanted electromedical devices, pregnancy, and relevant allergies. The work is being conducted at Changhai Hospital and aims to address the current scarcity of MCE image datasets.
Why it matters
Potential benefit: If successful, the database could enable more accurate and earlier noninvasive diagnosis by supporting AI tools trained on diverse, well-annotated images.
How similar studies have gone: AI studies using EGD and CT images have shown promising diagnostic results, but MCE image datasets are sparse and combining MCE with linked pathology in a database is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female participants aged ≥ 18 years 2. Patients with early upper gastrointestinal cancer referred for endoscopic submucosal dissection (ESD), or patients with upper gastrointestinal precancerous lesions or precancerous conditions referred for biopsy by esophagogastroduodenoscopy (EGD) 3. Participants who are willing and able to participate in this study, complete all required examinations and follow-up visits, and who have provided written informed consent Exclusion Criteria: 1. Patients who are not eligible for surgery or who refuse any abdominal surgery in case of capsule retention and endoscopic retrieval failure 2. Patients with cardiac pacemaker or other implanted electromedical devices which could interfere with magnetic resonance 3. Suspected or known intestinal stenosis or other known risk factors for capsule retention 4. Patients with dysphagia 5. Pregnancy 6. Allergy to polymeric materials, latex, simethicone, or pronase 7. Patients plan to undergo magnetic resonance imaging examination before excretion of the capsule 8. Patients with any condition that precludes compliance with the study
Where it's running
-
Changhai Hosptial
Shanghai, China Recruiting
Study contacts
- Principal investigator: Jun Pan, MD — Changhai Hospital
- Study coordinator: Jun Pan, MD
- Email: panjun059@163.com
- Phone: +86-13764598567
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Precision navigation to boost cancer screening participation in high-risk communities
This study tests whether a personalized navigation program helps adults aged 45–74 in Chinese communities who are at high risk for several cancers to complete recommended free cancer screenings.
-
Exercise training after upper gastrointestinal cancer surgery
This trial tests whether high-intensity interval training or low-intensity aerobic training after curative surgery helps people recover better than usual care.
-
Laparoscopic and endoscopic dual-scope surgery for early stomach cancer
This trial tests a stomach-preserving approach that combines laparoscopy and endoscopy to remove early gastric cancer while marking the area with a fluorescent tracer.
-
Single-use gastroscopes vs reusable in elective and subacute gastroscopy
This study tests whether single-use gastroscopes work as well as reusable ones for adults having gastroscopy when endoscope reprocessing capacity is limited.
-
Bedside single-use gastroscopes versus reusable gastroscopes in the endoscopy unit for subacute inpatients
This test will see if using single-use gastroscopes at the bedside shortens the time from referral to gastroscopy compared with sending hospitalized adults to the endoscopy unit with reusable scopes.
-
Comparing single-use and reusable gastroscopes in surgery
This study tests whether single-use gastroscopes work as well as reusable ones for patients needing a gastroscopy for upper gastrointestinal issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.